Maureen Therese Cronin Net Worth

What's Maureen Cronin's mailing address?

Maureen's mailing address filed with the SEC is 16305 36TH AVENUE NORTH, , MINNEAPOLIS, MN, 55446.

Insiders trading at Celcuity Inc

Over the last 7 years, insiders at Celcuity Inc have traded over $452,378 worth of Celcuity Inc stock and bought 317,370 units worth $2,387,116 . The most active insiders traders include Brian F. Sullivan, Richard Nigon a Polly A. Murphy. On average, Celcuity Inc executives and independent directors trade stock every 67 days with the average trade being worth of $147,164. The most recent stock trade was executed by Richard E Buller on 23 August 2024, trading 350 units of CELC stock currently worth $5,933.

What does Celcuity Inc do?

celcuity is a biotech company developing state-of-the-art cell-based assays using our proprietary functional cellular analysis platform. we directly assess the functionality of the disease-related signaling pathways of a patient's diseased cells ex vivo to determine whether a drug therapy has the intended effect on those cells. the patient specific cellular data we provide offers clinicians and pharmaceutical companies unique insight into a patient's response to a drug therapy, and it will change the paradigm of personalized medicine.

Celcuity Inc executives and stock owners

Celcuity Inc executives and other stock owners filed with the SEC include:

• Dr. Lance G. Laing,
  Co-Founder, Chief Science Officer, VP, Sec. & Director
• Brian F. Sullivan,
  Co-Founder, Chairman & CEO
• Vicky Hahne,
  Chief Financial Officer
• Igor Gorbatchevsky,
  MD & VP of Clinical Devel.
• Dr. Arthur P. DeCillis M.D.,
  Chief Medical Officer
• Bernhard Lampert Ph.D.,
  Head of CMC
• Marie DeGayner Kuker,
  Head of Regulatory
• Sheri Smith,
  Acting Head of Clinical Operations
• Dr. John R. MacDonald Ph., Dabt,
  Sr. VP of R&D
• Dr. Arthur P. DeCillis,
  Chief Medical Officer
• Eric Lindquist,
  Chief Bus. Officer
• Vicky Hahne,
  Chief Financial Officer
• Richard Nigon,
  Director
• David Dalvey,
  Director
• Maureen Therese Cronin,
  Director
• Leo Furcht,
  Director
• Richard E Buller,
  Director
• Polly A. Murphy,
  Director
• Lance G. Laing,
  Chief Science Officer
• Brian F. Sullivan,
  Chief Executive Officer